Jennifer Gordon, PhD, Associate Professor of Neuroscience at the Center for Neurovirology at the Lewis Katz School of Medicine at Temple University (LKSOM), spoke with KYW Newsradio about a new study published in the journal Molecular Therapy in which Temple researchers reported that a drug used in the treatment of HIV also suppresses Zika virus infection. Kamel Khalili, PhD, Laura H. Carnell Professor and Chair of the Department of Neuroscience and Director of the Center for Neurovirology and the Comprehensive NeuroAIDS Center at LKSOM, is the senior investigator on the study. Dr. Khalili credited the breakthrough to collaboration among colleagues, including Dr. Gordon and Ilker K. Sariyer, DVM, PhD, Associate Professor of Neuroscience at the Center for Neurovirology at LKSOM. Contagion Live and Healthcare Purchasing News also covered the news.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH